📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination. (2017)

First Author: Manning NM

Attributed to: African horse sickness: Effector mechanisms of immunity and viral determinants of pathogenicity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2017.04.005

PubMed Identifier: 28438410

Publication URI: http://europepmc.org/abstract/MED/28438410

Type: Journal Article/Review

Volume: 35

Parent Publication: Vaccine

Issue: 44

ISSN: 0264-410X